by Felicia Lenzo | Sep 3, 2015 | News
Dr. Morrison, president of OmniSeq℠ Precision Medicine Technology, is featured as a “leading voice” in precision medicine. Buffalo, NY – June 29, 2015—The digital publication Future of Personal Health focuses on precision medicine in an article entitled Precision...
by Felicia Lenzo | Sep 3, 2015 | News
Company Expands Member Network to Advance the Clinical Utility of Genomic Medicine Buffalo, NY – August 03, 2015 – OmniSeq, LLC today announced the addition of the Wilmot Cancer Institute to the OmniSeqSM Genomic Network. Recently, OmniSeq officially spun out from...
by Felicia Lenzo | Sep 3, 2015 | News
By Alan Rosenhoch, Featuring Carl Morrison, MD, DVM Dr. Carl Morrison is founder, president and chief scientific officer of OmniSeq LLC – a recent Roswell Park Cancer Institute spinoff genomics firm. At Roswell Park, Dr. Morrison continues in his roles as Executive...
by Felicia Lenzo | Sep 1, 2015 | News
WOBURN, Mass., Sept. 1, 2015 /PRNewswire/ — truXTRAC is a comprehensive novel solution for clinical-grade DNA extraction from Formalin-Fixed, Paraffin-Embedded (FFPE) tissues utilizing Covaris Adaptive Focused Acoustics® (AFA™) technology. The unique focused,...
by Felicia Lenzo | Aug 19, 2015 | News
Buffalo has an emerging cluster of companies dedicated to cancer treatment that are showing significant signs of progress. Of course, the formation of oncology companies is nothing new in Buffalo, especially given institutional research strongholds like the University...
